Publications by authors named "Xando Diaz-Villamarin"

Claim this Profile
C
Clinical Pharmacogenetics: Results After Implementation of Preemptive Tests in Daily Routine.
Xando Díaz-Villamarín, María Martínez-Pérez, María Teresa Nieto-Sánchez, Emilio Fernández-Varón, Alicia Torres-García

J Pers Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-Limiting Toxicities and the Maximum Tolerated Dose of Irinotecan Based on Genotypes: A Systematic Review.
Xando Díaz-Villamarín, María Teresa Nieto-Sánchez, María Martínez-Pérez, Paula Novo-González, Emilio Fernández-Varón

Pharmaceutics· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between gut and nasopharyngeal microbiome composition can predict the severity of COVID-19.
Benita Martin-Castaño, Patricia Diez-Echave, Jorge García-García, Laura Hidalgo-García, Antonio Jesús Ruiz-Malagon

Elife· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Digestive Decontamination: A Comprehensive Approach to Reducing Nosocomial Infections and Antimicrobial Resistance in the ICU.
María Martínez-Pérez, Rosario Fernández-Fernández, Rocío Morón, María Teresa Nieto-Sánchez, María Eugenia Yuste

J Clin Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study.
Xando Díaz-Villamarín, María Martínez-Pérez, María Teresa Nieto-Sánchez, Gabriela Ruiz-Tueros, Emilio Fernández-Varón

Pharmaceutics· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation.
Xando Díaz-Villamarín, Emilio Fernández-Varón, Michelle Carolina Rojas Romero, José Luis Callejas-Rubio, José Cabeza-Barrera

Biomed Pharmacother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study.
Margarita-Ioanna Koufaki, Vasileios Fragoulakis, Xando Díaz-Villamarín, Kariofyllis Karamperis, Athanassios Vozikis

Hum Genomics· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics of siponimod: A systematic review.
Xando Díaz-Villamarín, Raquel Piñar-Morales, Francisco Javier Barrero-Hernández, Alba Antúnez-Rodríguez, José Cabeza-Barrera

Biomed Pharmacother· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Polymorphisms in VEGFR Coding Genes (/) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients.
David Blánquez-Martínez, Xando Díaz-Villamarín, Sonia García-Rodríguez, Alba Antúnez-Rodríguez, Ana Pozo-Agundo

Pharmaceutics· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Polymorphisms Affecting Ranibizumab Response in High Myopia Patients.
David Blánquez-Martínez, Xando Díaz-Villamarín, Alba Antúnez-Rodríguez, Ana Pozo-Agundo, José Ignacio Muñoz-Ávila

Pharmaceutics· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic polymorphisms affecting bisoprolol response.
Celia Castaño-Amores, Xando Díaz-Villamarín, Ana María Pérez-Gutiérrez, Alba Antúnez-Rodríguez, Ana Pozo-Agundo

Biomed Pharmacother· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis.
Xando Díaz-Villamarín, David Blánquez-Martínez, Ana Pozo-Agundo, Ana María Pérez-Gutiérrez, José Ignacio Muñoz-Ávila

Genes (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention.
Vasilios Fragoulakis, Marina Bartsakoulia, Xando Díaz-Villamarín, Konstantina Chalikiopoulou, Konstantina Kehagia

Pharmacogenomics J· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine.
Cristina Lucía Dávila-Fajardo, Xando Díaz-Villamarín, Alba Antúnez-Rodríguez, Ana Estefanía Fernández-Gómez, Paloma García-Navas

Genes (Basel)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The study protocol for a non-randomized controlled clinical trial using a genotype-guided strategy in a dataset of patients who undergone percutaneous coronary intervention with stent.
Cristina Lucía Dávila-Fajardo, Jesús Sánchez-Ramos, Xando Diaz- Villamarín, Luis Javier Martínez-González, Pablo Toledo Frías

Data Brief· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent.
Jesús Sánchez-Ramos, Cristina Lucía Dávila-Fajardo, Pablo Toledo Frías, Xando Díaz Villamarín, Luis Javier Martínez-González

Int J Cardiol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplasty.
Xando Díaz-Villamarín, Cristina Lucía Dávila-Fajardo, Luis Javier Martínez-González, Pedro Carmona-Sáez, Jesús Sánchez-Ramos

Pharmacogenomics· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population.
Hoi Y Tong, Cristina Lucía Dávila-Fajardo, Alberto M Borobia, Luis Javier Martínez-González, Rubin Lubomirov

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis